Dr. Tara Grabowsky, chief medical officer at Vencore, will give big data and predictive analytics and their role in rare disease diagnosis at the four-day 2015 Biotechnology Industry Organization International Convention in Philadelphia, which starts Monday.
Vencore said Thursday Grabowsky will also discuss privacy laws’ implications for patients with such conditions at the event.
Event attendees will also see the company’s health analytics platform, SiPFer, which works to extract diagnosis patterns and identify patients who may have received an inaccurate diagnosis and those with undiagnosed conditions.
“Combining big data with the right analytics help us find the proverbial needle in the haystack to join patients with the proper therapy,” said Mac Curtis, Vencore president and CEO and an inductee into Executive Mosaic’s Wash100 list for 2015.
“The pharmaceutical industry is fast developing new drug treatments for rare diseases, and now we can help get them to the right patients by applying the right analytics and insight to extract the maximum value from big data,” he added.